4 most recent filings and news items mentioning EXOZ. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/EXOZ/news?limit=20"
Pull EXOZ filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/daySpencer Fane LLP affirmed that the securities associated with eXoZymes Inc.'s shelf registration drawdown are legally valid. This opinion confirms the company's compliance with securities regulations, supporting the current issuance of 71,110 shares and 35,555 warrants via Public
View filing at SEC.gov →eXoZymes Inc. received a $2.03 million NIH grant to advance cannabinoid analogs. The funding validates the company's platform amid the rapidly growing minor cannabinoids market.
View filing at SEC.gov →eXoZymes Inc. completed an underwritten public offering of 330,575 units at $8.99 per share, raising approximately $5.95 million in gross proceeds before expenses. The company plans to use net proceeds for development of its NCT product candidate, advancing other product opportun
View filing at SEC.gov →eXoZymes Inc. filed an 8-K regarding a shelf drawdown offering of common stock and warrants under Form S-3 registration. The offering includes 592,270 shares and 296,135 warrants with potential over-allotment coverage, with Public Ventures LLC as underwriter.
View filing at SEC.gov →